Assignee
HEALTH PROT AGENCY
GB·24 granted patents·8 pending applications·781 citations·filing 1999–2011
Top patents by PatentIndex Score
32 records- 0198US7192596B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2002·Granted Mar 20, 2007·160 cites·42 claims
- 0298US6962703B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsHEALTH PROT AGENCY·Filed 2002·Granted Nov 8, 2005·111 cites·29 claims
- 0397US6632440B1Methods and compounds for the treatment of mucus hypersecretionHEALTH PROT AGENCY·Filed 1999·Granted Oct 14, 2003·263 cites·19 claims
- 0491US7674470B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2005·Granted Mar 9, 2010·13 cites·30 claims
- 0590US8012479B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2009·Granted Sep 6, 2011·4 cites·16 claims
- 0689US7384645B2Outer membrane vesicles from gram negative bacteria and use as a vaccineHEALTH PROT AGENCY·Filed 2002·Granted Jun 10, 2008·45 cites·4 claims
- 0788US7208466B1Use of a lectin or conjugates for modulation of c-fibre activityHEALTH PROT AGENCY·Filed 2000·Granted Apr 24, 2007·31 cites·4 claims
- 0884US8003776B2Mycobacterial antigens expressed during latencyHEALTH PROT AGENCY·Filed 2008·Granted Aug 23, 2011·7 cites·23 claims
- 0984US7303907B2Degradation and detection of TSE infectivityHEALTH PROT AGENCY·Filed 2003·Granted Dec 4, 2007·12 cites·14 claims
- 1083US7393539B2Mycobacterial antigens expressed under low oxygen tensionHEALTH PROT AGENCY·Filed 2002·Granted Jul 1, 2008·20 cites·25 claims
- 1183US7193066B1Preparation of highly pure toxin fragmentsHEALTH PROT AGENCY·Filed 2000·Granted Mar 20, 2007·23 cites·10 claims
- 1281US7393540B2Mycobacterial antigens expressed during latencyHEALTH PROT AGENCY·Filed 2002·Granted Jul 1, 2008·15 cites·17 claims
- 1380US8017753B2Mycobacterial antigens expressed under low oxygen tensionHEALTH PROT AGENCY·Filed 2008·Granted Sep 13, 2011·3 cites·24 claims
- 1480US7811588B2Mycobacterial genes down-regulated during latencyHEALTH PROT AGENCY·Filed 2002·Granted Oct 12, 2010·12 cites·6 claims
- 1576US7758856B2Bacteriophage for the treatment of bacterial biofilmsHEALTH PROT AGENCY·Filed 2004·Granted Jul 20, 2010·16 cites·40 claims
- 1673US7670796B2Metalloprotease assayHEALTH PROT AGENCY·Filed 2004·Granted Mar 2, 2010·9 cites·20 claims
- 1770US7820185B2Stable compositions containing OMVsHEALTH PROT AGENCY·Filed 2005·Granted Oct 26, 2010·1 cites·21 claims
- 1867US6660264B1Treatment of intracellular infectionHEALTH PROT AGENCY·Filed 2000·Granted Dec 9, 2003·8 cites·10 claims
- 1966US6913896B1Assay with reduced backgroundHEALTH PROT AGENCY·Filed 2000·Granted Jul 5, 2005·9 cites·10 claims
- 2064US2004071736A1Methods and compounds for the treatment of mucus hypersecretionHEALTH PROT AGENCY·Filed 2003·Application pending·0 cites
- 2161US6821521B1Multicomponent meningococcal vaccineHEALTH PROT AGENCY·Filed 1999·Granted Nov 23, 2004·16 cites·8 claims
- 2261US2011244453A1Salmonella detection assayHEALTH PROT AGENCY·Filed 2009·Application pending·0 cites
- 2358US7422740B1Use of lytic toxins and toxin conjugatesHEALTH PROT AGENCY·Filed 2000·Granted Sep 9, 2008·3 cites·4 claims
- 2458US2007184048A1Re-targeted toxin conjugatesHEALTH PROT AGENCY·Filed 2004·Application pending·0 cites
- 2557US2010092519A1Compositions comprising polysaccharide conjugates and their use as vaccinesHEALTH PROT AGENCY·Filed 2008·Application pending·0 cites
- 2654US8372405B2Proteins with improved solubility and methods for producing and using sameHEALTH PROT AGENCY·Filed 2011·Granted Feb 12, 2013·0 cites·12 claims
- 2751US2007154495A1Modified whole cell, cell extract and omv-based vaccinesHEALTH PROT AGENCY·Filed 2004·Application pending·0 cites
- 2844US7935480B2Detection of nucleic acid mutations by detecting the presence of heteroduplexesHEALTH PROT AGENCY·Filed 2005·Granted May 3, 2011·0 cites·37 claims
- 2938US2009087877A1Infectivity assayHEALTH PROT AGENCY·Filed 2007·Application pending·0 cites
- 3035US2011262484A1Outer membrane vesicle prime-protein boost vaccineHEALTH PROT AGENCY·Filed 2009·Application pending·0 cites
- 3133US7157245B2Neisserial vaccine compositions and methodsHEALTH PROT AGENCY·Filed 2001·Granted Jan 2, 2007·0 cites·10 claims
- 3230US2010003740A1Chemically defined culture medium for neisseriaHEALTH PROT AGENCY·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HEALTH PROT AGENCY files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →